Q2 2021 Talis Biomedical Corp Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Talis Second Quarter 2021 Earnings Call. (Operator Instructions)
I would now like to turn the conference over to Ms. Emily Faucette, SVP, Corporate Communications and Investor Relations. Ma'am, please go ahead.
Good afternoon, and thank you for participating in today's conference call. Joining me, we have Brian Coe, our Chief Executive Officer; Roger Moody, our Chief Financial Officer; and Doug Liu, our Chief Operating Officer. Earlier today, Talis released financial results and business progress for the quarter ended June 30, 2021. A copy of that press release can be accessed on the Investors page of our website at talisbio.com.
Before we get started, I would like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |